Pictet Group’s wholly owned alternative investment business Pictet Alternative Advisors (PAA) has added to its thematic private equity franchise with the launch of a strategy focused on biotech and healthcare investments.
The new strategy aims to invest in biotech and healthcare-focused venture capital, growth and private equity funds globally and will make a "substantial" allocation to co-investments within five key segments in which it will make "high conviction" investments. Therapeutics, diagnostics, digital health, medical technology, and health care and services providers have been identified as the key segments for the strategy to invest in. Pierre Stadler, head of thematic private equity at PAA said: "From a private equity standpoint, the five areas provide opportunities across the full spectru...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes